Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02741648 · ClinicalTrials.gov registry record
RBC Irradiation, Anemia and Gut Injury
A clinical trial of Anemia and Necrotizing Enterocolitis, sponsored by Emory University.
- Active
- Registry status
- 324
- Enrollment target
- 3
- Study locations
NCT02741648: Active study of Anemia and Necrotizing Enterocolitis, sponsored by Emory University.
NCT02741648 is a study of Anemia and Necrotizing Enterocolitis that is active but no longer recruiting, run by Emory University. The registered enrollment target is 324 participants, below the 423-participant average among 72 other Anemia trials with a reported enrollment target (23% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02741648, a study of Anemia and Necrotizing Enterocolitis, is active but no longer recruiting, sponsored by Emory University.
- ACTIVE NOT RECRUITING
- Registry status
- 324 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this trial is to study the effect that anemia and red blood cell (RBC) transfusions have on oxygen levels in the digestive tracts of extremely low birth weight (ELBW) infants and to look for possible markers in a baby's blood, urine and/or stool that may lead to a better understanding of what makes an ELBW infant at risk for digestive tract problems such as necrotizing enterocolitis.
Primary Outcome
Mesenteric tissue oxygenation is measured in infants receiving RBC transfusion. Mesenteric regional saturation of oxygen (MES-rSO2) levels are measured via the INVOS 5100C Cerebral/Somatic Oximeter by applying an adhesive sensor probe to the patient's periumbilical area for mesenteric monitoring. MES-rSO2 will be compared between infants receiving RBC transfusion with and without IST.
Conditions Studied
Interventions
- DEVICE Near Infrared Spectroscopy
- OTHER Non-invasive Image-based Anemia Assessment
Study Locations (3)
Georgia
- Grady Memorial Hospital - Atlanta
- Emory University Hospital Midtown - Atlanta
- Northside Hospital - Neonatology - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 324 participants |
| Start Date | 2016-07 |
| Est. Completion | 2026-02-28 |
What the registry record for NCT02741648 still lists
NCT02741648 is an observational study that tracks outcomes without assigning an intervention. The registered 324 participants enrollment target is mid-sized for trials with a published cap, below the 423-participant average among 72 other Anemia trials with a reported enrollment target (23% lower).
The record links to 2 conditions, with Anemia appearing as the primary indexed condition, and to 2 interventions - of which Near Infrared Spectroscopy is the first listed.
NCT02741648 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT02741648 about?
NCT02741648 is a clinical study titled "RBC Irradiation, Anemia and Gut Injury". The purpose of this trial is to study the effect that anemia and red blood cell (RBC) transfusions have on oxygen levels in the digestive tracts of extremely low birth weight (ELBW) infants and to look for possible markers in a baby's blood, urine and/or stool that may lead to a better understanding...
What is the current status of trial NCT02741648?
This trial is currently active not recruiting. The enrollment target is 324 participants. The study started on 2016-07. Estimated completion is 2026-02-28.
What conditions does trial NCT02741648 study?
This clinical trial studies the following conditions: Anemia, Necrotizing Enterocolitis.
What interventions are being tested in trial NCT02741648?
The interventions under investigation include: Near Infrared Spectroscopy (DEVICE), Non-invasive Image-based Anemia Assessment (OTHER).
Who is sponsoring clinical trial NCT02741648?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02741648 being conducted?
This trial has 3 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02741648's enrollment target sits among peer trials
324 21st of 72 higher than 51 of 72 other Anemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
RECRUITING · Phase 2
-
Study of DISC-0974-201 in Participants With IBD and Anemia
RECRUITING · Phase 2
-
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
RECRUITING · Phase 1
-
129Xe MRI Cardiopulmonary
RECRUITING · Phase 2
-
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
RECRUITING · Phase 3
-
177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04164173 · 324 participants · NA
Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
- NCT04708054 · 324 participants · Phase 2
Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
- NCT05261399 · 324 participants · Phase 3
Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment
- NCT05353322 · 324 participants · NA
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia